Skip to content
← Full study record

NCT00243074 · OUTCOME

Objective Response Rate Per Modified RECIST for Pleural Tumors

S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery · Source last updated 2018-01-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
Disease assessments for response were performed every 8 weeks as long as the patient remained on protocol treatment, up to 5 years.

What was measured

The sum of 6 pleural thickness measurements is added to sum of the longest diameters of all non-pleural measurable lesions. The resulting values are evaluated using RECIST.

Analysis population: Eligible patients who received any amount of AZD2171

Groups in this outcome

AZD2171

Not reported

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
AZD217147

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
AZD21712Not reported011Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0
        upper Limit
        11
        value
        2
denoms
  1. counts
    1. group Id
      OG000
      value
      47
    units
    Participants
description
The sum of 6 pleural thickness measurements is added to sum of the longest diameters of all non-pleural measurable lesions. The resulting values are evaluated using RECIST.
dispersion Type
95% Confidence Interval
groups
  1. id
    OG000
    title
    AZD2171
param Type
NUMBER
population Description
Eligible patients who received any amount of AZD2171
reporting Status
POSTED
time Frame
Disease assessments for response were performed every 8 weeks as long as the patient remained on protocol treatment, up to 5 years.
title
Objective Response Rate Per Modified RECIST for Pleural Tumors
type
SECONDARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice